JENNIFER MONDILLO: Open Payments
NPI 1366737660 · SCHWENKSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172,483 in 246 payments from 6 companies in 2025. Trend: 2023 $112,220 · 2024 $110,811 · 2025 $172,483
Speaker / faculty: $117,864Consulting: $27,015Travel & lodging: $21,655Food & beverage: $5,949
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 202 | $155,046 |
| Otsuka America Pharmaceutical, Inc. | 29 | $16,103 |
| ACADIA Pharmaceuticals Inc | 12 | $952 |
| E.R. Squibb & Sons, L.L.C. | 1 | $315 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $55 |
| Alpha Cognition USA, Inc. | 1 | $13 |
Products named: INGREZZA, REXULTI, NUPLAZID, Zunveyl.
Industry payments across PA — which companies pay providers there.
